ProShare Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.7M | Sell |
249,935
-56,234
| -18% | -$4.5M | 0.02% | 301 |
|
|
2025
Q4 | $29.2M | Buy |
306,169
+26,021
| +9% | +$2.55M | 0.05% | 251 |
|
|
2025
Q3 | $27.4M | Sell |
280,148
-6,577
| -2% | -$681K | 0.06% | 249 |
|
|
2025
Q2 | $30.8M | Buy |
286,725
+49,430
| +21% | +$5M | 0.06% | 241 |
|
|
2025
Q1 | $23.9M | Buy |
237,295
+12,415
| +6% | +$1.25M | 0.05% | 251 |
|
|
2024
Q4 | $20.1M | Buy |
224,880
+24,022
| +12% | +$2.11M | 0.05% | 254 |
|
|
2024
Q3 | $16.8M | Sell |
200,858
-15,181
| -7% | -$1.2M | 0.04% | 268 |
|
|
2024
Q2 | $16.6M | Buy |
216,039
+16,430
| +8% | +$1.2M | 0.04% | 259 |
|
|
2024
Q1 | $13.7M | Sell |
199,609
-5,219
| -3% | -$336K | 0.04% | 280 |
|
|
2023
Q4 | $11.8M | Sell |
204,828
-19,838
| -9% | -$1.06M | 0.04% | 285 |
|
|
2023
Q3 | $11.9M | Sell |
224,666
-5,763
| -3% | -$302K | 0.04% | 282 |
|
|
2023
Q2 | $12.5M | Buy |
230,429
+9,002
| +4% | +$470K | 0.04% | 280 |
|
|
2023
Q1 | $11.1M | Buy |
221,427
+27,488
| +14% | +$1.3M | 0.03% | 290 |
|
|
2022
Q4 | $8.97M | Sell |
193,939
-5,469
| -3% | -$237K | 0.03% | 328 |
|
|
2022
Q3 | $7.72M | Sell |
199,408
-22,700
| -10% | -$911K | 0.03% | 332 |
|
|
2022
Q2 | $8.28M | Sell |
222,108
-84,707
| -28% | -$3.45M | 0.03% | 374 |
|
|
2022
Q1 | $13.6M | Sell |
306,815
-8,600
| -3% | -$373K | 0.03% | 306 |
|
|
2021
Q4 | $13.4M | Buy |
315,415
+69,892
| +28% | +$2.94M | 0.03% | 311 |
|
|
2021
Q3 | $10.7M | Buy |
245,523
+350
| +0.1% | +$15.5K | 0.03% | 328 |
|
|
2021
Q2 | $10.5M | Buy |
245,173
+40,583
| +20% | +$1.71M | 0.03% | 359 |
|
|
2021
Q1 | $7.91M | Sell |
204,590
-9,375
| -4% | -$355K | 0.02% | 400 |
|
|
2020
Q4 | $7.69M | Buy |
213,965
+18,901
| +10% | +$681K | 0.03% | 384 |
|
|
2020
Q3 | $7.45M | Sell |
195,064
-21,488
| -10% | -$828K | 0.03% | 336 |
|
|
2020
Q2 | $7.6M | Buy |
216,552
+1,135
| +0.5% | +$40.9K | 0.04% | 307 |
|
|
2020
Q1 | $7.03M | Sell |
215,417
-45,131
| -17% | -$1.76M | 0.05% | 302 |
|
|
2019
Q4 | $11.8M | Buy |
260,548
+33,951
| +15% | +$1.42M | 0.05% | 325 |
|
|
2019
Q3 | $9.22M | Buy |
226,597
+10,033
| +5% | +$425K | 0.05% | 332 |
|
|
2019
Q2 | $9.31M | Sell |
216,564
-34,672
| -14% | -$1.33M | 0.06% | 316 |
|
|
2019
Q1 | $9.64M | Buy |
251,236
+9,070
| +4% | +$346K | 0.06% | 291 |
|
|
2018
Q4 | $8.56M | Buy |
242,166
+10,511
| +5% | +$381K | 0.06% | 256 |
|
|
2018
Q3 | $8.92M | Sell |
231,655
-17,608
| -7% | -$615K | 0.06% | 252 |
|
|
2018
Q2 | $8.15M | Sell |
249,263
-13,114
| -5% | -$396K | 0.05% | 273 |
|
|
2018
Q1 | $7.17M | Buy |
262,377
+8,788
| +3% | +$239K | 0.05% | 343 |
|
|
2017
Q4 | $6.29M | Buy |
253,589
+98,613
| +64% | +$2.72M | 0.04% | 379 |
|
|
2017
Q3 | $4.52M | Buy |
154,976
+22,200
| +17% | +$613K | 0.04% | 393 |
|
|
2017
Q2 | $3.68M | Sell |
132,776
-3,454
| -3% | -$91.7K | 0.04% | 419 |
|
|
2017
Q1 | $3.39M | Buy |
136,230
+1,602
| +1% | +$39K | 0.04% | 427 |
|
|
2016
Q4 | $2.91M | Buy |
134,628
+26,018
| +24% | +$568K | 0.03% | 453 |
|
|
2016
Q3 | $2.58M | Sell |
108,610
-55,155
| -34% | -$1.32M | 0.04% | 418 |
|
|
2016
Q2 | $3.83M | Buy |
163,765
+4,028
| +3% | +$87.1K | 0.05% | 296 |
|
|
2016
Q1 | $3M | Sell |
159,737
-76,716
| -32% | -$1.35M | 0.04% | 342 |
|
|
2015
Q4 | $4.36M | Buy |
236,453
+12,261
| +5% | +$220K | 0.05% | 314 |
|
|
2015
Q3 | $3.68M | Buy |
224,192
+10,121
| +5% | +$173K | 0.05% | 326 |
|
|
2015
Q2 | $3.79M | Sell |
214,071
-34,896
| -14% | -$624K | 0.05% | 336 |
|
|
2015
Q1 | $4.42M | Sell |
248,967
-22,314
| -8% | -$353K | 0.05% | 336 |
|
|
2014
Q4 | $3.59M | Buy |
271,281
+43,249
| +19% | +$553K | 0.04% | 399 |
|
|
2014
Q3 | $2.69M | Sell |
228,032
-23,294
| -9% | -$293K | 0.04% | 553 |
|
|
2014
Q2 | $3.21M | Sell |
251,326
-20,877
| -8% | -$271K | 0.04% | 468 |
|
|
2014
Q1 | $3.68M | Sell |
272,203
-6,512
| -2% | -$85.5K | 0.05% | 382 |
|
|
2013
Q4 | $3.35M | Buy |
278,715
+115,407
| +71% | +$1.36M | 0.05% | 478 |
|
|
2013
Q3 | $1.92M | Sell |
163,308
-64,765
| -28% | -$701K | 0.05% | 428 |
|
|
2013
Q2 | $2.11M | Buy |
+228,073
| New | +$1.93M | 0.04% | 436 |
|
Other funds holding BSX
VCM
VPM
ProShare Advisors's BSX Position: Q1 2026 in Review
ProShare Advisors reduced its Boston Scientific (BSX) stake by 18% in Q1 2026, selling an estimated $4.5M and leaving 249,935 shares worth $15.7M. The position accounts for 0.02% of the portfolio, ranked #301.
ProShare Advisors first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.8M in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- ProShare Advisors held 249,935 shares of Boston Scientific worth $15.7M as of Q1 2026.
- ProShare Advisors sold 56,234 Boston Scientific shares in Q1 2026, an estimated $4.5M.
- Boston Scientific made up 0.02% of ProShare Advisors's portfolio in Q1 2026, its #301 holding.
- ProShare Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- ProShare Advisors's Boston Scientific position peaked at $30.8M in Q2 2025.
- 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.